Acute and subacute hemorrhagic leukoencephalitis [Hurst]
ICD-10 G36.1 is a billable code used to indicate a diagnosis of acute and subacute hemorrhagic leukoencephalitis [hurst].
Acute and subacute hemorrhagic leukoencephalitis, also known as Hurst's disease, is a rare neurological condition characterized by the rapid onset of inflammation and hemorrhage in the white matter of the brain. This condition is often associated with viral infections, particularly those affecting the central nervous system, and can lead to significant neurological deficits. Clinically, patients may present with symptoms such as altered mental status, seizures, focal neurological deficits, and signs of increased intracranial pressure. The pathophysiology involves demyelination and necrosis of the white matter, which can be exacerbated by underlying conditions such as multiple sclerosis or other demyelinating diseases. Diagnosis typically requires neuroimaging, such as MRI, which may reveal characteristic lesions, and cerebrospinal fluid analysis to identify inflammatory markers. Treatment often involves immunomodulatory therapies, including corticosteroids and antiviral agents, aimed at reducing inflammation and managing symptoms. The prognosis varies, with some patients experiencing recovery while others may have persistent neurological impairments.
Detailed clinical notes including symptom onset, neurological examination findings, and imaging results.
Patients presenting with acute neurological deficits, seizures, or altered mental status.
Ensure comprehensive documentation of the patient's history and any prior demyelinating conditions.
Clear imaging reports detailing findings consistent with hemorrhagic leukoencephalitis.
MRI findings in patients with suspected acute neurological conditions.
Radiologists should correlate imaging findings with clinical symptoms for accurate coding.
Used to evaluate acute neurological symptoms.
Document indications for imaging and findings.
Neurologists should correlate imaging results with clinical symptoms.
Indicated for suspected acute hemorrhagic leukoencephalitis.
Detailed report of findings and clinical correlation.
Ensure imaging is performed in a timely manner to guide treatment.
Key symptoms include sudden onset of seizures, altered mental status, focal neurological deficits, and signs of increased intracranial pressure.
G36.1 is characterized by acute symptoms and hemorrhagic changes on imaging, while multiple sclerosis is a chronic condition with relapsing-remitting episodes.
